S2C3, an analog of dequalinium, is an HIV-1 fusion inhibitor that specifically binds to the gp41 membrane proximal external region (MPER) of the HIV-1 envelope spike and blocks CD4-induced conformational changes. S2C3 effectively block HIV-1 infection. S2C3 (CYDE-21) is a cationic amphiphilic bolaamphiphile nano-sized vesicles or vesicle-like aggregates suitable to carry antisense oligonucleotides (ASO) into bacterium such as C. difficile.
HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes
Nature Chemical Biology, 16 (2020)
Cationic amphiphilic bolaamphiphile-based delivery of antisense oligonucleotides provides a potentially microbiome sparing treatment for C. difficile
The Journal of Antibiotics, 71 (2018)
Questions
Reviews
★★★★★ No rating value
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.